In this podcast, Valerie Bowling, Director of PODD, walks you through what to expect at PODD 2019 in under 4 minutes. The 9th annual PODD conference features the following:

Building a Company around a Transformative Drug Delivery Invention with MIT's Dr Robert Langer, Dr Sangeeta Bhati, Dr Giovanni Traverso and Harvard Medical School's Dr Jeffrey Karp.
Modality Fluid Development: Tales of Evolving Pipelines and Drug Delivery Solutions with Merck's, VP, Pharmaceutical Sciences, Dr Allen Templeton
Gene Therapy Keynote with Spark Therapeutics, President and Head of R&D, Dr Katherine High
Zeitgeist Presentation on Immune Targeting Nanomedicine by AstraZeneca’s, VP, External Innovation and Novel Product Technologies, Dr Anand Subramony
Conference Chair opening remarks provided by AstraZeneca's, Dr Shawn Davis

Additional Featured Speakers:

Roche’s, Senior Portfolio Strategy Director, Dr Beate Bittner will moderate the Formulation & Device Lifecycle Management for Biotherapeutics – Clinical and Industry Perspectives on Subcutaneous Delivery panel.
Drug Delivery Pipeline and Technologies, A Year in Review, with Pharmacircle’s, VP, Kurt Sedo
Delivering Flexible Dosage Forms with Pfizer's Dr Advait Badkar

The 9th annual PODD conference will take place on October 7-8, 2019 in Boston, MA. Learn more at theconferenceforum.org

PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes

Share

Embed